Press Release: Ximedica Partners with MedTech Innovator for 2018 Competition
Dec 12, 2017
Providence, RI - Ximedica announced today the organization will be continuing our partnership with MedTech Innovator for their 2018 MedTech Innovator Showcase and MedTech Innovator Competition. The competition will be held in conjunction with AdvaMed’s MedTech Conference, September 24th through 26th in Philadelphia.
The call has been made for startup and emerging-growth companies to apply to the 2018 competition by January 26th. Nearly 600 completed applications were submitted for the 2017 competition, and MedTech Innovator is anticipating a record-breaking number of submissions for the high-profile program in 2018. During the competition held at the AdvaMed MedTech Conference in San Francisco this past September, an audience of industry leaders selected Day Zero Diagnostics as the 2017 grand-prize winner of $350,000. Applications are reviewed by more than 150 executives and professionals from dozens of leading manufacturers, providers, and investors, including Ximedica for the second year in a row.
“We’re truly excited to yet again partner with MedTech Innovator for another successful competition and accelerator,” says Tracy MacNeal, EVP of Corporate Development for Ximedica. “We’re looking forward to seeing all the new talent and networking with other industry leaders who also recognize the value in advising startups in the medical device, diagnostics, and digital health space.”
As part of the competition and accelerator, the leading applicants will be invited to present at one of MedTech Innovator’s regional pitch events in the United States, Europe, Canada, and Israel throughout March and April 2018. Ximedica representatives will also attend and participate in these events.
“Every substantial development project faces a gauntlet of product design, organizational, and system choices that need to be navigated. For an early stage company, those choices can be ‘make or break’ moments, with consequences that last longer than you imagine,” Jong Lee, CEO of Day Zero Diagnostics, said. “Ximedica understands that terrain, and their investment in us has helped our team be faster, smarter, and more decisive about our choices. Their commitment to working with an entrepreneurial company like us has been fantastic.”
About MedTech Innovator
MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Our mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator 2018 features startup companies that address one or more of the transformative themes identified in an annual survey of leading manufacturers and providers. To learn more about MedTech Innovator, visit https://medtechinnovator.org/ and follow @MedTechAwards on Twitter.
Ximedica is a full-service ISO 13485-certified and FDA-registered medical device and diagnostics product development firm. For 30 years Ximedica has provided a unique growth platform enabling organizations to successfully deploy medical technology products into the market. Its headquarters are in Providence, R.I., with offices in Hong Kong, Minneapolis, San Francisco and Los Gatos. In November of 2014, SV LifeSciences, a Boston-based private equity firm, acquired a majority stake in Ximedica, enabling the company to execute its growth strategy. For more about Ximedica, visit http://www.ximedica.com/.